Guidance

Notification of product discontinuations: pharmaceuticals

Best practice guidelines on stopping the supply of a medicine.

From:
Department of Health and Social Care
Published
2 May 2001

This publication was withdrawn on

This guidance is no longer current. Updated guidance on reporting requirements for medicine shortages and discontinuations was published on 20 March 2019.

Applies to England

Documents

Ensuring best practice in the notification of product discontinuations: best practice guidelines

PDF, 414 KB, 10 pages

Pro-forma for product discontinuation

MS Word Document, 18.2 KB

Details

These guidelines, recommended jointly by the Department of Health and the Association of the British Pharmaceutical Industry, make recommendations about who to tell, when and what information will be needed when discontinuing medicines. They also include a timetable for notification of withdrawal from at least 12 months before deletion.

Updates to this page

Published 2 May 2001

Sign up for emails or print this page